Background and objectives Chronic kidney disease is a persistent chronic health condition commonly seen in pediatric nephrology programs. Our study aims to evaluate the sensitivity of the Patient Reported Outcomes Measurement Information System (PROMIS) pediatric instrument to indicators of disease severity and activity in pediatric chronic kidney disease. -014-2858-8 depression, anxiety, social-peer relationships, pain interference, fatigue, mobility, and upper extremity function, were administered via web-based questionnaires. Absolute effect sizes (AES) were generated to demonstrate the impact of disease on domain scores. Four children were excluded because of missing glomerular filtration rate (GFR) estimations. Results Of the 229 children included in the final analysis, 221 completed the entire PROMIS questionnaire. Unadjusted PROMIS domains were responsive to chronic kidney disease activity indicators and number of coexisting conditions. PROMIS domain scores were worse in the presence of recent hospitalizations (depression AES 0.33, anxiety AES 0.42, pain interference AES 0.46, fatigue AES 0.50, mobility AES 0.49), edema (depression AES 0.50, anxiety AES 0.60, pain interference AES 0.77, mobility AES 0.54) and coexisting medical conditions (social peer-relationships AES 0.66, fatigue AES 0.83, mobility AES 0.60, upper extremity function AES 0.48). Conclusions The PROMIS pediatric domains of depression, anxiety, social-peer relationships, pain interference, and mobility were sensitive to the clinical status of children with chronic kidney disease in this multi-center cross sectional study. We demonstrated that a number of important clinical characteristics including recent history of hospitalization and edema, affected patient perceptions of depression, anxiety, pain interference, fatigue and mobility. The PROMIS instruments provide a potentially valuable tool to study the impact of chronic kidney disease. Additional studies will be required to assess responsiveness in PROMIS score with changes in disease status over time.
Introduction
Individuals with chronic kidney disease represent a growing population in adult and pediatric practices. This has resulted in a drive to optimize patient care and outcomes [1] . Chronic kidney disease in children encompasses a broad range of etiologies including congenital anomalies of the kidney and urinary tract, cystic kidney diseases and glomerulopathies. In addition to the clinical measures of kidney function, assessment of health-related quality of life through patient reported outcomes can elucidate and quantify the patient perspective on health and disease.
The impact of chronic kidney disease on the health-related quality of life of pediatric patients has been increasingly studied over the past several years. Patients with end-stage kidney disease receiving dialysis have been shown to have significantly lower health-related quality of life in all domains measured on the generic Pediatric Inventory of Quality of Life Scales (Peds QL 4.0™) and the end-stage kidney disease specific PedsQL 3.0™ [2] [3] [4] . Studies examining the impact of renal transplant on the health-related quality of life of patients have yielded divergent results [2, 5, 6] . Gerson et al. [7] recently demonstrated through the use of the PedsQL 4.0 that children with mild to moderate chronic kidney disease had significantly lower physical, emotional, school, and social domain scores. Each of these studies has confirmed the negative impact of chronic kidney disease on health-related quality of life in children.
The Patient Reported Outcomes Measurement Information System (PROMIS) project was established as part of the National Institutes of Health Roadmap Initiative to create item banks for both adults and children, which are publically available, efficient, precise, and valid across a variety of diseases to assess patient reported outcomes (www. nihpromis.org). In the initial phase of PROMIS, nine item banks specific to selected symptoms and quality of life were developed using qualitative and quantitative methods to measure child self-reported outcomes: depression, anxiety, social-peer relationships, pain interference, fatigue, mobility, upper extremity function, anger, and asthma impact in children 8-17 years old [8] [9] [10] [11] [12] . Previously most health-related quality of life research instruments utilized classical test theory in their development [13] , but the PROMIS instrument was developed using newer psychometric techniques also referred to as item response theory [14] . Item response theory has allowed PROMIS to create banks of items that measure an underlying trait (e.g., Fatigue) and gives the user (researcher, clinician) the option to use any subset of the items in the bank to measure the trait. Any subset of the items can be combined to generate a score (PROMIS score) that is comparable with other studies using items from the bank. PROMIS also developed item banks that do not require attribution of a symptom to a disease. This allows comparison of scores across diseases or for patients with multiple chronic diseases. Currently, the PROMIS item banks are undergoing validity studies in a variety of populations including children with asthma, sickle cell disease, cancer, nephrotic syndrome, inflammatory bowel disease, and obesity [15] [16] [17] . The validation of the PROMIS instrument becomes particularly important in pediatric clinical research and pediatric therapeutics as patient reported outcomes are becoming standard clinical trial endpoints and their use is encouraged by the Food and Drug Administration [18] .
This study aims to evaluate the sensitivity of the PROMIS instruments to pediatric chronic kidney disease severity (Stage I-III, Stage IV-V, and Renal Transplant), and activity indicators, such as edema and recent hospitalizations. We hypothesized that the PROMIS instruments would demonstrate worse patient reported outcomes in children with a greater degree of chronic kidney disease severity and activity.
Methods
This cross sectional study was conducted by the Midwest Pediatric Nephrology Consortium (MWPNC) and included 233 pediatric patients from 16 participating member institutions. Each site obtained individual institutional IRB approval. Parents and children gave informed consent and assent respectively, prior to performing the study.
Training study team members
Research personnel at each site received web-based training in study procedures; the study operations manual was a reference tool for study conduct, quality control, and recruitment. Ongoing education of site personnel occurred during investigator and coordinator conference calls.
Eligibility
The PROMIS kidney cohort study included children 8-17 years old with chronic kidney disease defined as having end stage kidney disease requiring dialysis, a kidney transplant, or estimated glomerular filtration rate (eGFR)<90 ml/ min/1.73 m 2 [19] . Eligibility criteria included the ability to speak and read English. Exclusion criteria included coexisting medical, psychiatric, or cognitive impairments that would prevent the patient from answering the computerized questionnaire. Children with nephrotic syndrome were not included in this analysis as this population has been previously reported [16] .
Study procedures
The parent completed the Family and Medical Information form, which included relationship to child, guardian education level, socioeconomic, and disease specific questions. Child characteristics included: gender, age, race, ethnicity, disease etiology, dialysis, transplant, co-existing conditions, hospitalizations in the previous 6 months, surgery in the previous 12 months, number of medications, corticosteroid therapy, self-rated edema status, and the guardian's perception of the child's weight status (underweight, healthy weight or overweight). Clinical data such as diagnosis and eGFR were obtained from the patient medical record by the local investigators. Chronic kidney disease stage was assigned based on eGFR as defined by the Kidney Disease Outcomes Quality Initiative [20] .
The children completed the domains related to depression, anxiety, social-peer relationships, pain interference, fatigue, mobility, and upper extremity function. The definitions of the domains are located at http://www.nihpromis.org/measures/ domainframework2 . All of the PROMIS items use the context statement "In the past 7 days." Responses include five options ranging from "never" to "almost always" in the majority of domains and from "with no trouble" to "not able to do" for the physical functioning measures. Each pediatric PROMIS domain generates a T-score where 50 is the mean and 10 the standard deviation in the initial PROMIS calibration population. Higher scores indicate more of the measured symptom, thus signifying worse symptoms of depression, anxiety, fatigue, and pain interference and better functioning for mobility, upper extremity function, and peer relationships. These measures have been previously tested in a large group of children and adolescents, confirming their unidimensionality and the extent to which each item was associated with the measured variable (www.assessmentcenter.net) [8, [10] [11] [12] 14] . The trait-level-specific reliabilities of scores on the pediatric PROMIS measures have been≥0.85 in a 2-4 standard deviation score range of the domains being measured [10] [11] [12] 14] .
In order to decrease the response burden, a sampling plan was devised and is summarized in Table 1 . Briefly, participants were randomly assigned to one of two study arms by the Assessment Center after they were registered to take the survey, which included the assignment of the long form for either the pain interference or fatigue domain and the short or long form version of all the other domains. Using this strategy, children completed 70-90 questions over 30-40 min.
Statistical analysis
Frequencies and percentages were calculated for demographic and clinical characteristics. Means and standard deviations were calculated for eGFR scores and number of medications. For the purpose of domain analysis, chronic kidney disease was divided in stage I-III, stage IV-V, and renal transplant. Mean scores as well as standard deviations were calculated for each of the seven domains by long and short form. To assess the association of long-form versus short-form scores, Pearson's correlations were calculated where applicable. The long-form and short-form domain scores for all domains were very highly correlated, with Pearson's r ranging 0.95-1.0. Consequently, short-form mean scores are presented in this manuscript and compared across the study sample by chronic kidney disease stage with greater stage showing an increase in disease severity, indicating poorer kidney function and transplant status. Mean scores were also compared across the disease activity indicators of recent hospitalization, recent surgery, edema status and number of coexisting medical conditions. Because the domain variables were not normally distributed, comparisons were also performed using nonparametric Wilcoxon test for two-sample comparison and Kruskal-Wallis test for multiple-sample comparison. Published guidelines were used to define the magnitude of absolute effect sizes (AES) based on the ranges of Cohen's d values: "small"=0.0-0.4, "medium" =0.5-0.7 and "large" ≥ 0.8 [21] . For variables with more than one category, Cohen's d was calculated using the categories with the highest and lowest means. Simultaneous regression analyses were conducted to assess and interpret the association of child characteristics with each of the five domains with complete scores. All statistical analyses were conducted using SAS v9.2.
Results
Child demographic and disease characteristics, as well as guardian demographic are presented in Table 2 . Four children were excluded because of missing GFR estimations. There were 229 children in the final analysis including those with chronic kidney disease stage I-III (N=106, 46 %), stage IV-V (N=38, 17 %), and renal transplant (N=85, 37 %). Underlying chronic kidney disease etiology included congenital urologic abnormalities (N=114, 50 %), glomerular disease (N=68, 30 %), and other (N=47, 21 %). About one-third of the children reported recent hospitalizations (N=75, 33 %). Twelve percent (N=27) reported presence of edema; 11 had glomerular disease and 16 had non-glomerular disease. Fifty (22 %) children reported two or more co-existing medical conditions. A total of eight children were missing one or more of the PROMIS domain scores. Four children had missing scores for one of the PROMIS domains and four children ended the survey early. Missing data, from either incomplete assessments or missing a single domain, were not associated with any of the following explanatory variables of interest: chronic kidney disease (CKD) stage, transplant, hospitalizations, surgery, edema, number of medications, and coexisting medical conditions, or patient age. Tables 3 and 4 show the actual number of children that completed each domain. Table 3 shows domain scores for depression, anxiety, and social-peer relationships. Markers of disease activity, including recent hospitalizations and edema, predicted worse scores. Patients who experienced recent hospitalizations had worse depression and anxiety scores (AES 0.33 and 0.42, respectively). The presence of edema was also associated with more difficulties with depression and anxiety (AES 0.50 and 0.60, respectively). Co-existing conditions were also associated with worse social-peer relationship scores (AES 0.66). Table 4 includes domain scores for pain interference, fatigue, mobility and upper extremity function separately. Chronic kidney disease severity was associated with worse mobility (AES 0.41) scores. Markers of disease activity including recent hospitalizations and edema predicted worse domain scores. Recent hospitalization was associated with worse scores pain interference (AES 0.46), fatigue (AES 0.50), and mobility (AES 0.49). The presence of edema was associated with significantly worse scores in pain interference (AES 0.77), mobility (AES 0.54) and was borderline with fatigue (AES 0.63, p=0.05). The number of coexisting medical conditions was associated with worse fatigue (AES 0.83), mobility (AES 0.60) and upper extremity function (AES 0.48).
Analysis of disease characteristics and PROMIS domains
Children with glomerular disease were analyzed separately as a sensitivity analysis (data not shown). The domain scores did not differ significantly between children with glomerular diseases and the remainder of the study population with the exception of upper extremity function where children with glomerular disease had significantly better function (p<0.05). Figure 1 shows a comparison between the children with chronic kidney disease reported in this manuscript and those with nephrotic syndrome previously reported [16] . The domain scores did not differ significantly between children with 
Multivariate results
Multivariate results are reported in Table 5 . Overall, the PROMIS instruments were sensitive to markers of chronic kidney disease activity including recent hospitalization and edema. Children with hospitalization in the past 6 months had a four-point worse score for depression and a five-point worse score for anxiety (p<0.05, Table 5 ). Children with edema on average had a six-point worse score for depression, six-point worse score for anxiety, and four-point worse score for mobility (p<0.05, Table 5 ). Co-existing medial conditions also predicted worse PROMIS scores. Those with two or more coexisting medical conditions had on average a four-point worse score in depression, five-point worse score in anxiety, eightpoint worse score in social-peer relationships, four-point worse score in mobility, and three-point worse score in upper extremity function (p<0.05).
Discussion
As children with chronic kidney disease survive into adulthood, the impact of chronic illness on their health-related quality of life has been increasingly recognized and studied, yet not routinely addressed in clinical practice. We present a multi-center study evaluating the PROMIS instrument as a measure of patient reported outcomes in children with chronic kidney disease. We demonstrate that the PROMIS instrument distinguishes between children with chronic kidney disease with and without markers of disease activity. We also report a novel finding demonstrating the importance of co-existing medical conditions on the patient reported outcomes of patients with chronic kidney disease. The PROMIS instruments are potentially valuable tools for researchers who seek to study the impact of chronic kidney disease on children. Recent studies have indicated that children with chronic kidney disease or nephrotic syndrome are vulnerable to health-related quality of life challenges involving impact on physical, school, emotional, and social functioning [7, 16, 22] . In children who are initiating dialysis, psychological problems have been identified and often persist into adulthood [23, 24] . However there are limited studies offering insight into the characteristics of the disease experience that may impact health-related quality of life. Our group has recently reported on the importance of edema in children with nephrotic syndrome and its impact on patient-reported outcomes as a measure of health-related quality of life [16] . Previous studies in children with chronic kidney disease that investigated these issues have focused on long-term factors associated with chronic kidney disease such as short stature and anemia [25, 26] , but have not investigated distinct near-term and long-term factors influencing patient reported outcomes. In this study, we show that the PROMIS instrument identified specific nearterm and long-term factors affecting patient reported outcomes, including hospitalization in the past 6 months, current edema status, and co-existing conditions.
The need for hospitalization often represents a worsening of clinical status, but also represents a significant upheaval in a child's life with separation from their normal routine and interaction with friends, family, and school. Our study demonstrated that children with chronic kidney disease who have been hospitalized in the past 6 months had significantly worse scores for depression, anxiety, pain, fatigue, and mobility. Furthermore, in multivariate analysis, the need for hospitalization remained predictive of worse depression and anxiety in children with chronic kidney disease. These results are consistent with previous reports showing that children with chronic kidney disease had significant psychosocial burdens [7, 22, 27, 28] .
Edema represents one of the most visibly evident symptoms of chronic kidney disease. The impact of edema on patients includes physical appearance, mobility challenges, and pain. Our team recently reported worse health-related quality of life in children with nephrotic syndrome with edema in the domains of anxiety, pain interference, fatigue, and mobility [16] . PROMIS scores demonstrated similar findings in children with chronic kidney disease showing that the b Difference between groups significant at p<0.01
c Difference between groups significant at p<0.001
presence of edema was associated with worse depression, anxiety, pain, fatigue, and mobility. It is understandable that children would have issues with pain, fatigue, and mobility as the presence of edema can directly contribute to these physical attributes. The depressive and anxiety symptoms may reflect the loss of disease control that edema represents. The impact of treatment on patient reported outcomes in edematous children remains to be explored. The importance of co-existing conditions in patients with chronic kidney disease may go unrecognized in the midst of subspecialty care. Gerson et al. [7] demonstrated that children with comorbidities had a worse parent-proxy physical, social and emotional scores and children self-reported worse social scores. In our study, other health conditions were present in nearly 50 % of participants. Our data confirm the findings of Gerson et al., showing worse social-peer interactions. Our study also found worse depression, anxiety, fatigue and mobility for patients with increasing number of co-existing conditions in multivariate analysis. Taken together, these studies emphasize the importance of focusing on the whole patient, since the pediatric nephrology practice often serves as the medical home for patients with chronic kidney disease.
Interestingly, we did not demonstrate a significant difference between individuals with end-stage kidney disease, preend stage kidney disease, and kidney transplant with respect to self-reported quality of life. The literature on this topic has shown mixed results when comparing patients with renal transplant to children with varying degrees of chronic kidney disease and those on dialysis. In studies that have relied on child self-report, it is typical not to find significant differences in health-related quality of life after renal transplant compared with children prior to transplant [4, 27, 29] . One may postulate that the small sample size of end-stage kidney disease patients in our study may explain the lack of significant differences across chronic kidney disease severity. Overall, however, our findings suggest that the impact of chronic kidney disease on the health-related quality of life in children lies with markers of disease activity that directly impact a child including the presence of edema and recent hospitalizations.
Limitations of this study should be noted. This study utilized a within-patient comparison and did not include healthy controls. This shows the strength of the PROMIS instrument in that it is able to detect clinically meaningful differences within disease specific patient samples. There are studies currently underway to characterize the PROMIS instrument in healthy subjects as well as to characterize minimally important differences that can be used to inform analysis of longitudinal within patient comparisons. The PROMIS instrument is limited by the age of patients that can provide selfreport and was designed for children ages 8-17 years. At the time of this study only an English version of the Pediatric PROMIS instrument was available. Following the launch of this project, PROMIS parent proxy-report items have been developed for age 5-17 years. These resources will enrich future research. Lastly, this study was cross sectional and does not document longitudinal changes.
Among the strengths of this study is the inclusion of patients from a wide variety of socio-economic and clinical backgrounds. This represents one of the broadest patient samplings studying patient reported outcomes in children with chronic kidney disease.
Conclusion
This is the first step in the validation process for the pediatric PROMIS instrument in chronic kidney disease. Future prospective longitudinal studies, healthy control samples, crossdisease and cross-instrument comparisons will be necessary to identify the best use of PROMIS in pediatric kidney disease research and patient care environments. This study demonstrated that the pediatric PROMIS instrument was sensitive to differences in clinical status within a sample of children with chronic kidney disease. The scores were worse with clinical indicators of disease activity and with co-existing conditions. Future work will need to advance the investigation of the pediatric PROMIS self-report in longitudinal analysis, initiate assessment of the parent proxy instrument, and comparison to legacy instruments.
